Plasma Volume
6
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Effects of Creatine and Heat Exposure on Exercise Performance and Body Water Distribution
Inflammatory Responses After CrossFit and Resistance Trainings in Untrained Subjects
HighCycle Study: Acetazolamide, High Altitude and Plasma Volume
Effect of Tidal Volume Change on Pressure-based Prediction of Fluid Responsiveness in Children
Cyclic Variation in Micronutrient Concentrations and Plasma Volume
A Study of the Effects of Canagliflozin on Plasma Volume in Patients With Type 2 Diabetes Mellitus